Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier.

Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Abstract Text:

    takeyori sahekiTakeyori Saheki,keiko kobayashiKeiko Kobayashi,mikio iijimaMikio Iijima,mitsuaki moriyamaMitsuaki Moriyama,masahide yazakiMasahide Yazaki,yo-ichi takeiYo-Ichi Takei,shu-ichi ikedaShu-Ichi Ikeda,

    Citrin, encoded by SLC25A13, is a liver-type mitochondrial aspartate-glutamate carrier (AGC), of which deficiency, in autosomal recessive trait, causes neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2). NICCD patients have jaundice, hypoproteinemia, hypoglycemia, galactosemia, growth retardation, fatty liver and multiple aminoacidemia including citrulline, methionine, threonine and tyrosine. Some of the neonates who have experienced NICCD suffer from severe CTLN2 more than 10 years or several decades later. In CTLN2, neuropsychotic symptoms such as disorientation, aberrant behavior, coma and death are observed. Laboratory findings reveal hyperammonemia, citrullinemia, fatty liver and liver-specific decrease in a urea cycle enzyme, argininosuccinate synthetase (ASS). In some cases, hyperlipidemia, pancreatitis and hepatoma are accompanied with CTLN2. Citrin as a liver-type AGC plays a role in supplying aspartate to the cytosol for urea, protein and nucleotide synthesis by exchanging mitochondrial aspartate for cytosolic glutamate and proton, and transporting cytosolic NADH reducing equivalent to mitochondria as a member of malate aspartate shuttle essential for aerobic glycolysis. AGC is also important for gluconeogenesis from lactate. Although it is difficult to explain pathogenesis of the symptoms such as cholestasis in NICCD and liver-specific decrease of ASS protein in CTLN2 from the functions of the AGC, some are understandable by the loss of citrin functions. Many CTLN2 patients have been treated with a low protein and high carbohydrate diet and glycerol at the hyperammonemic coma. We argue that those treatments may result in fatty liver, hyperlipidemia, hyperammonemia and even death due to loss of the citrin functions. Loss of citrin first cause deficiency of aspartate in the cytosol, which results in an increase in cytosolic NADH/NAD(+) ratio and then activation of fatty acid synthesis pathway to compensate the aberrant ratio. This follows inhibition of fatty acid oxidation. The peculiar fondness for food of CTLN2 patients who like protein and dislike carbohydrate and sweets may be related to their metabolic requirements.

    Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Publishing Authors By Initials

    t sahekiT Saheki,k kobayashiK Kobayashi,m iijimaM Iijima,m moriyamaM Moriyama,m yazakiM Yazaki,y takeiY Takei,s ikedaS Ikeda,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Hepatology research : the official journal of the

    VOLUME: 33

    Page Numbers: 181-4

    Journal Abbreviation:

    ISSN: 1386-6346

    DAY: 30

    MONTH: 09

    YEAR: 2005

    Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9711801

    Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier.

    AFFILIATION: Department of Molecular Metabolism and Biochemical Genetics, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1, Sakuragaoka, Kagoshima 890-8544, Japan.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Hepatol Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News